Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 631

1.

The effect of serum vitamin B12, folate, ferritin levels and transferrin saturation on stem cell mobilization in allogeneic donors.

Yiğenoğlu TN, Başcı S, Bakırtaş M, Ulu BU, Kılınç A, Şahin D, Darçın T, Yıldız J, Merdin A, Baysal NA, İskender D, Çakar MK, Dal MS, Hacıbekiroğlu T, Altuntaş F.

Transfus Apher Sci. 2020 Jan 9:102726. doi: 10.1016/j.transci.2020.102726. [Epub ahead of print]

PMID:
32008954
2.

Efficiency of day 4 compared to day 6 stem cell mobilization in allogeneic stem cell donors.

Al-Geithi H, Al-Mamari S, Dennison D, Al-Huneini M, Al-Kindi S, Al-Farsi K, Al-Khabori M.

Transfus Apher Sci. 2020 Jan 9:102727. doi: 10.1016/j.transci.2020.102727. [Epub ahead of print]

PMID:
31948917
3.

CD44 mediates stem cell mobilization to damaged lung via its novel transcriptional targets, Cortactin and Survivin.

Ouhtit A, Thouta R, Zayed H, Gaur RL, Fernando A, Rahman M, Welsh DA.

Int J Med Sci. 2020 Jan 1;17(1):103-111. doi: 10.7150/ijms.33125. eCollection 2020.

4.

Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma.

Marr K, Ronsley R, Nadel H, Douglas K, Gershony S, Strahlendorf C, Davis JH, Deyell RJ.

Pediatr Blood Cancer. 2020 Apr;67(4):e28167. doi: 10.1002/pbc.28167. Epub 2020 Jan 11.

PMID:
31925920
5.

A retrospective study of autologous stem cell mobilization by G-CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma.

Zheng G, He J, Cai Z, He D, Luo Y, Shi J, Wei G, Sun J, Zheng W.

Oncol Lett. 2020 Jan;19(1):1051-1059. doi: 10.3892/ol.2019.11177. Epub 2019 Dec 3.

6.

Low baseline platelet count predicts poor response to plerixafor in patients with multiple myeloma undergoing autologous stem cell mobilization.

Bakeer M, Zubair AC, Roy V.

Cytotherapy. 2020 Jan;22(1):16-20. doi: 10.1016/j.jcyt.2019.10.008. Epub 2019 Dec 24.

PMID:
31879152
7.

Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield.

Furundarena JR, Uranga A, Alkorta A, González C, Javier Ferreiro J, Rey M, Aragón L, Urreta I, Emparanza JI, Redín H, Garrido A, Araiz M.

Int J Lab Hematol. 2019 Dec 12. doi: 10.1111/ijlh.13142. [Epub ahead of print]

PMID:
31830371
8.

Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

Abdallah N, Kim S, Ayash L, Klimecki S, Ventimiglia M, Alavi A, Ratanatharathorn V, Uberti J, Deol A.

Bone Marrow Transplant. 2019 Nov 18. doi: 10.1038/s41409-019-0744-5. [Epub ahead of print] No abstract available.

PMID:
31740765
9.

Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients.

Shumilov E, Novak U, Jeker B, Mansouri Taleghani B, Bacher U, Pabst T.

Hemasphere. 2019 Feb 8;3(2):e176. doi: 10.1097/HS9.0000000000000176. eCollection 2019 Apr. No abstract available.

10.

Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans.

Nakasone H, Kikuchi M, Kawamura K, Akahoshi Y, Sato M, Kawamura S, Yoshino N, Takeshita J, Yoshimura K, Misaki Y, Gomyo A, Tanihara A, Kusuda M, Tamaki M, Kimura SI, Kako S, Kanda Y.

Sci Rep. 2019 Nov 11;9(1):16499. doi: 10.1038/s41598-019-53020-9.

11.

Agreements and uncertainties in autologous haematopoietic stem cell mobilization and collection. A Spanish consensus document.

Bueno JL, Alegre A, López-Villar O, Querol S, Arroyo JL, Goterris R, Sureda A, García-Gala JM, Amunarriz C, Albo C, Fernández-Fuertes F, Medina L, Antelo ML, Blanquer M, Vallejo C, Canales M, Vidales-Mancha I, Duarte RF.

Bone Marrow Transplant. 2019 Nov 6. doi: 10.1038/s41409-019-0716-9. [Epub ahead of print]

PMID:
31690809
12.

Induction therapy and stem-cell mobilization in myeloma, look at the past to plan the future.

Schaffel R.

Hematol Transfus Cell Ther. 2019 Oct - Dec;41(4):283-284. doi: 10.1016/j.htct.2019.09.001. Epub 2019 Oct 8. No abstract available.

13.

Comparison of Various Hematopoietic Stem Cell Mobilization Regimens in Patients with Lymphoma and Myeloma.

Yilmaz Ü, Salim O, Yücel OK, Iltar U, Ündar L.

Clin Lab. 2019 Oct 1;65(10). doi: 10.7754/Clin.Lab.2019.190214.

PMID:
31625348
14.

Viagra Enables Efficient, Single-Day Hematopoietic Stem Cell Mobilization.

Smith-Berdan S, Bercasio A, Rajendiran S, Forsberg EC.

Stem Cell Reports. 2019 Nov 12;13(5):787-792. doi: 10.1016/j.stemcr.2019.09.004. Epub 2019 Oct 10.

15.

An updated single center experience with plerixafor and granulocyte colony-stimulating factor for stem cell mobilization in light chain amyloidosis.

Badar T, Dhakal B, Szabo A, Padmanabhan A, Johnson BD, Heidtke S, Esselmann J, Chhabra S, Hamadani M, Hari P, D'Souza A.

J Clin Apher. 2019 Dec;34(6):686-691. doi: 10.1002/jca.21747. Epub 2019 Sep 30.

PMID:
31566813
16.

Effect of intermittent hyperoxia on stem cell mobilization and cytokine expression.

MacLaughlin KJ, Barton GP, Braun RK, Eldridge MW.

Med Gas Res. 2019 Jul-Sep;9(3):139-144. doi: 10.4103/2045-9912.266989.

17.

Evaluation of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in Japanese healthy donors: a prospective study.

Sato K, Ishiyama K, Aoki G, Maruyama H, Tsuji N, Tanabe M, Zaimoku Y, Sato H, Yamazaki H, Yamaguchi M, Takami A, Nakao S.

Int J Hematol. 2019 Dec;110(6):648-653. doi: 10.1007/s12185-019-02733-8. Epub 2019 Sep 21.

PMID:
31542851
18.

Results from a multicenter, noninterventional registry study for multiple myeloma patients who received stem cell mobilization regimens with and without plerixafor.

Morris C, Chabannon C, Masszi T, Russell N, Nahi H, Kobbe G, Krejci M, Auner HW, Pohlreich D, Hayden P, Basak GW, Lenhoff S, Schaap N, van Biezen A, Knol C, Iacobelli S, Liu Q, Celanovic M, Garderet L, Kröger N.

Bone Marrow Transplant. 2020 Feb;55(2):356-366. doi: 10.1038/s41409-019-0676-0. Epub 2019 Sep 18.

19.

Only minor stem cell mobilization in head and neck irradiated patients treated with hyperbaric oxygen.

Forner L, Berkowicz A, Dickmeiss E, Hyldegaard O, Jansen EC, Fischer-Nielsen A.

Diving Hyperb Med. 2019 Sep 30;49(3):175-185. doi: 10.28920/dhm49.3.175-185.

PMID:
31523792
20.

Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience.

Goker H, Ciftciler R, Demiroglu H, Turgut M, Sayınalp N, Haznedaroglu IC, Okay M, Tekin F, Buyukasık Y.

Transfus Apher Sci. 2019 Aug 8:102595. doi: 10.1016/j.transci.2019.06.023. [Epub ahead of print]

PMID:
31492570

Supplemental Content

Loading ...
Support Center